MIRA PHARMACEUTICALS, INC. (MIRA) — Institutional Holders, Q2 2026
26 institutional investment managers reported a MIRA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.2M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
MIRA in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- BlackRockAdded · +132,276 sh+$125.2K
- CAPTRUST FINANCIAL ADVISORSNew · +90,645 sh+$85.8K
- VANGUARD CAPITAL MANAGEMENTAdded · +57,889 sh+$54.8K
- CITADEL ADVISORSNew · +18,661 sh+$17.7K
- COMMONWEALTH EQUITY SERVICESAdded · +18,122 sh+$17.2K
Biggest sellers
- Suncoast Equity ManagementSold out · -90,645 sh-$85.8K
- Vanguard Global AdvisersSold out · -24,306 sh-$23.0K
- Frec MarketsSold out · -22,000 sh-$20.8K
- XTX Topco LtdTrimmed · -21,199 sh-$20.1K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPTrimmed · -6,580 sh-$6.2K
MIRA 13F holders ranked 1–26 of 26
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT#1 · 751,801 sh | 751,801 | $712.0K | 0.00% | +8.3% |
| 2 | Cross Staff Investments#2 · 359,401 sh | 359,401 | $340.2K | — | 0.0% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 303,882 sh | 303,882 | $287.6K | 0.00% | +4.5% |
| 4 | BlackRock#4 · 244,622 sh | 244,622 | $231.5K | 0.00% | +117.7% |
| 5 | VANGUARD FIDUCIARY#5 · 170,668 sh | 170,668 | $161.6K | 0.00% | +0.7% |
| 6 | CAPTRUST FINANCIAL ADVISORS#6 · 90,645 sh | 90,645 | $85.8K | <0.01% | New |
| 7 | NORTHERN#7 · 67,735 sh | 67,735 | $64.1K | 0.00% | +0.1% |
| 8 | First American Bank#8 · 60,000 sh | 60,000 | $56.8K | <0.01% | 0.0% |
| 9 | COMMONWEALTH EQUITY SERVICES#9 · 53,189 sh | 53,189 | $50.3K | <0.01% | +51.7% |
| 10 | STATE STREET#10 · 49,100 sh | 49,100 | $46.5K | 0.00% | 0.0% |
| 11 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT#11 · 35,000 sh | 35,000 | $33.2K | <0.01% | 0.0% |
| 12 | FIFTH THIRD BANCORP#12 · 20,000 sh | 20,000 | $18.9K | 0.00% | 0.0% |
| 13 | CITADEL ADVISORS#13 · 18,661 sh | 18,661 | $17.7K | 0.00% | New |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#14 · 18,566 sh | 18,566 | $17.6K | 0.00% | -26.2% |
| 15 | Mariner#15 · 16,500 sh | 16,500 | $15.6K | 0.00% | 0.0% |
| 16 | XTX Topco Ltd#16 · 16,374 sh | 16,374 | $15.5K | <0.01% | -56.4% |
| 17 | HRT FINANCIAL#17 · 13,450 sh | 13,450 | $12.0K | 0.00% | New |
| 18 | CARY STREET PARTNERS FINANCIAL#18 · 10,000 sh | 10,000 | $9.5K | <0.01% | 0.0% |
| 19 | Federation des caisses Desjardins du Quebec#19 · 8,000 sh | 8,000 | $7.6K | 0.00% | 0.0% |
| 20 | OSAIC#20 · 2,000 sh | 2,000 | $1.9K | 0.00% | 0.0% |
| 21 | UBS Group AG#21 · 1,772 sh | 1,772 | $1.7K | 0.00% | -72.6% |
| 22 | CITIGROUP#22 · 1,207 sh | 1,207 | $1.1K | 0.00% | -71.4% |
| 23 | Steward Partners Investment Advisory#23 · 1,000 sh | 1,000 | $947.00 | 0.00% | -50.0% |
| 24 | Tower Research Capital (TRC)#24 · 517 sh | 517 | $489.00 | 0.00% | -89.6% |
| 25 | BARCLAYS PLC#25 · 159 sh | 159 | $150.00 | 0.00% | New |
| 26 | Caitong International Asset Management , Ltd#26 · 1 sh | 1 | $1.00 | 0.00% | 0.0% |
Funds that sold out of MIRA in Q2 2026 (4)
Held MIRA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Suncoast Equity Management90,645 sh | 90,645 | $97.0K |
| Vanguard Global Advisers24,306 sh | 24,306 | $26.0K |
| Frec Markets22,000 sh | 22,000 | $23.5K |
| WELLS FARGO & COMPANY23 sh | 23 | $25.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.